{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:39:36Z","timestamp":1762508376310,"version":"3.41.2"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T00:00:00Z","timestamp":1612828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To determine the long-term normal tissue complication probability with stereotactic body radiation therapy (SBRT) treatments for targets that move with respiration and its relation with the type of respiratory motion management (tracking <jats:italic>vs<\/jats:italic>. compression or gating).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A PubMed search was performed for identifying literature regarding dose, volume, fractionation, and toxicity (grade 3 or higher) for SBRT treatments for tumors which move with respiration. From the identified papers logistic or probit dose-response models were fitted to the data using the maximum-likelihood technique and confidence intervals were based on the profile-likelihood method in the dose-volume histogram (DVH) Evaluator.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Pooled logistic and probit models for grade 3 or higher toxicity for aorta, chest wall, duodenum, and small bowel suggest a significant difference when live motion tracking was used for targeting tumors with move with respiration which was on the average 10 times lower, in the high dose range.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Live respiratory motion management appears to have a better toxicity outcome when treating targets which move with respiration with very steep peripheral dose gradients. This analysis is however limited by sparsity of rigorous data due to poor reporting in the literature.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2020.591430","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T09:11:47Z","timestamp":1612861907000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Potential Clinical Significance of Overall Targeting Accuracy and Motion Management in the Treatment of Tumors That Move With Respiration: Lessons Learnt From a Quarter Century of Stereotactic Body Radiotherapy From Dose Response Models"],"prefix":"10.3389","volume":"10","author":[{"given":"Anand","family":"Mahadevan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahman","family":"Emami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimm","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence R.","family":"Kleinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin J.","family":"Redmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James S.","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Rostock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Kemmerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth M.","family":"Forster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Stanford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunjay","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sucha O.","family":"Asbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara A.","family":"LaCouture","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Scofield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Butterwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Muacevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,9]]},"reference":[{"key":"B1","article-title":"The stereotaxic method and radiosurgery of the brain","volume":"102","author":"Leksell","year":"1951","journal-title":"Acta Chir Scand"},{"key":"B2","article-title":"Sterotaxic radiosurgery in trigeminal neuralgia","volume":"137","author":"Leksell","year":"1971","journal-title":"Acta Chir Scand"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(88)90446-4","article-title":"A system for stereotactic radiosurgery with a linear accelerator","volume":"14","author":"Lutz","year":"1988","journal-title":"IJROBP"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1159\/000101628","article-title":"A new approach for direct CT localization in stereotaxis","volume":"45","author":"Barcia-Salorio","year":"1982","journal-title":"Appl Neurophysiol"},{"key":"B5","article-title":"Irradiations stereotaxiques multifaisceaux","volume":"28","author":"Betti","year":"1982","journal-title":"Neurochirurgie"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-198502000-00005","article-title":"External stereotactic irradiation by linear accelerator","volume":"16","author":"Colombo","year":"1985","journal-title":"Neurosurgery"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(85)90068-9","article-title":"Cerebral radiation surgery using moving field irradiation at a linear accelerator facility","volume":"11","author":"Hartmann","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3109\/02841869409121782","article-title":"Stereotactic radiotherapy of malignancies in the abdomen","volume":"33","author":"Lax","year":"1994","journal-title":"Methodol Aspects Acta Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.7759\/cureus.1","article-title":"Accuray, Inc. A Neurosurgical Business Case Study","volume":"1","author":"Adler","year":"2009","journal-title":"Cureus"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-5002(99)00019-7","article-title":"Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients","volume":"24","author":"Martel","year":"1999","journal-title":"Lung Cancer"},{"key":"B11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2004.07.691","article-title":"A challenge to traditional radiation oncology","volume":"60","author":"Fowler","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.03.045","article-title":"Local Control following Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer","author":"Lee","year":"","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3171\/2019.2.JNS181712","article-title":"Current and novel practice of stereotactic radiosurgery","volume":"130","author":"Kondziolka","year":"2019","journal-title":"J\u00a0Neurosurg"},{"key":"B15","unstructured":"DeppJG\n          Personal Communication, Founding President and CEO, Accuray Incorporated"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2012.04.007","article-title":"Low toxicity for lung tumors near the mediastinum treated with stereotactic body radiation therapy (SBRT)","volume":"3","author":"Srivastava","year":"2013","journal-title":"Pract Radiat Oncol April"},{"key":"B17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.semradonc.2015.11.005","article-title":"Introduction and Clinical Overview of the DVH Risk Map","volume":"26","author":"Asbell","year":"2016","journal-title":"Semin Radiat Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/31372149","article-title":"21 years of biologically effective dose","volume":"83","author":"Fowler","year":"2010","journal-title":"Br J Radiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(94)00475-Z","article-title":"Radiation dose-response of human tumors","volume":"32","author":"Okunieff","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(77)90062-1","article-title":"The assessment of the clinical significance of non-compliance with prescribed schedules of irradiation","volume":"2","author":"Herbert","year":"1977","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(94)00471-4","article-title":"Analysis of clinical complication data for radiation hepatitis using a parallel architecture model","volume":"31","author":"Jackson","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(01)01731-X","article-title":"Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data","volume":"51","author":"Levegr\u00fcn","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B23","unstructured":"Common Terminology Criteria for Adverse Events"},{"key":"B24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2307\/2340521","article-title":"On the Interpretation of x2 from Contingency Tables, and the Calculation of P","volume":"85","author":"Fisher","year":"1922","journal-title":"J Roy Stat Soc"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.02.032","article-title":"Radiological and clinical pneumonitis after stereotactic lung radiotherapy: a matched analysis of three-dimensional conformal and volumetric-modulated arc therapy techniques","volume":"80","author":"Palma","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2015.11.001","article-title":"Validity of Current Stereotactic Body Radiation Therapy Dose Constraints for Aorta and Major Vessels","volume":"26","author":"Xue","year":"2016","journal-title":"Semin Radiat Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2015.11.003","article-title":"Dose-response model for chest wall tolerance of stereotactic body radiation therapy","volume":"26","author":"Kimsey","year":"2016","journal-title":"Semin Radiat Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2015.12.002","article-title":"Dose-Volume Histogram Analysis of Stereotactic Body Radiotherapy Treatment of Pancreatic Cancer: A Focus on Duodenal Dose Constraints","volume":"26","author":"Goldsmith","year":"2016","journal-title":"Semin Radiat Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2015.11.009","article-title":"Small Bowel Dose Tolerance for Stereotactic Body Radiation Therapy","volume":"26","author":"LaCouture","year":"2016","journal-title":"Semin Radiat Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000260","article-title":"Toxicities of organs at risk in the mediastinal and hilar regions following stereotactic body radiotherapy for centrally located lung tumors","volume":"9","author":"Nishimura","year":"2014","journal-title":"J Thorac Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.03.053","article-title":"Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer","volume":"82","author":"Mutter","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijrobp.2013.05.012","article-title":"Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT)","volume":"87","author":"Barney","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B33","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-11572-1","volume-title":"Technical Basis of Radiation Therapy: Practical Clinical Applications","author":"Levitt","year":"2012"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(91)90172-Z","article-title":"Fitting of normal tissue tolerance data to an analytic function","volume":"21","author":"Burman","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.clon.2017.09.007","article-title":"UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy","volume":"30","author":"Hanna","year":"2018","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1120\/jacmp.v12i2.3368","article-title":"Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy","volume":"12","author":"Grimm","year":"2011","journal-title":"J\u00a0Appl Clin Med Phys"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2017.04.007","article-title":"Emphasis on Repair, Not Just Avoidance of Injury, Facilitates Prudent Stereotactic Ablative Radiotherapy","volume":"27","author":"Kim","year":"2017","journal-title":"Semin Radiat Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2008.08.001","article-title":"Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non\u2013small-cell lung cancer","volume":"72","author":"Chang","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B40","unstructured":"RothJ\n            ChangJ\n            KomakiR\n            KreslJ\n          International randomized study to compare CyberKnife stereotactic radiotherapy with surgical resection in stage I non-small cell lung cancer (STARS)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1118\/1.3579139","article-title":"Report of AAPM TG 135: quality assurance for robotic radiosurgery","volume":"38","author":"Dieterich","year":"2011","journal-title":"Med Phys"},{"key":"B42","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s12194-018-00495-2","article-title":"Performance evaluation of the CyberKnife system in real-time target tracking during beam delivery using a moving phantom coupled with two-dimensional detector array","volume":"12","author":"Yang","year":"2019","journal-title":"Radiol Phys Technol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rrw103","article-title":"A robust measurement point for dose verification in delivery quality assurance for a robotic radiosurgery system","volume":"58","author":"Kurosu","year":"2017","journal-title":"J Radiat Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1118\/1.4930961","article-title":"Factors that may determine the targeting accuracy of image-guided radiosurgery","volume":"42","author":"Subedi","year":"2015","journal-title":"Med Phys"},{"key":"B45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s13566-018-0371-6","article-title":"Volume Effects in Radiosurgical Spinal Cord Dose Tolerance: How Small is Too Small","volume":"8","author":"Ma","year":"2019","journal-title":"J Radiat Oncol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.06.094","article-title":"Improving normal tissue complication probability models: the need to adopt a \u201cdata-pooling\u201d culture","volume":"76","author":"Deasy","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.08.074","article-title":"The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome","volume":"76","author":"Jackson","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(93)90230-S","article-title":"Tolerance of cranial nerves of the cavernous sinus to radiosurgery","volume":"27","author":"Tishler","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(03)00529-7","article-title":"Unexpected changes of rat cervical spinal cord tolerance caused by inhomogeneous dose distributions","volume":"57","author":"Bijl","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.08.030","article-title":"Spinal cord tolerance to reirradiation with single-fraction radiosurgery: a swine model","volume":"83","author":"Medin","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(91)90153-U","article-title":"Carcinoma of the lung: hyperfractionation or resection and chemotherapy","volume":"20","author":"Fowler","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(95)00545-A","article-title":"A rationale for fractionation for slowly proliferating tumors such as prostatic adenocarcinoma","volume":"32","author":"Fowler","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(96)00579-2","article-title":"Cell kinetic measurements in prostate cancer","volume":"37","author":"Haustermans","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(98)00438-6","article-title":"Fractionation and protraction for radiotherapy of prostate carcinoma","volume":"43","author":"Brenner","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(01)01607-8","article-title":"Is alpha\/beta for prostate tumors really low","volume":"50","author":"Fowler","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(03)00132-9","article-title":"What hypofractionated protocols should be tested for prostate cancer","volume":"56","author":"Fowler","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(76)90149-8","article-title":"Changes in functional vascularity and cell number following x-irradiation of a murine carcinoma","volume":"1","author":"Clement","year":"1976","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B58","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1148\/127.3.799","article-title":"Tumor reoxygenation and postirradiation vascular changes","volume":"127","author":"Clement","year":"1978","journal-title":"Radiology"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.04.070","article-title":"Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer","volume":"78","author":"Brown","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B60","article-title":"In regard to Brown et al. (Int J Radiat Oncol Biol Phys2010;78:323-327)","volume":"80","author":"Koch","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.ijrobp.2010.11.014","article-title":"Stereotactic ablative radiotherapy in the framework of classical radiobiology: response to Drs. Brown, Diehn, and Loo","volume":"79","author":"Meyer","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.05.021","article-title":"Response to \u201cStereotactic ablative radiotherapy in the framework of classical radiobiology: response to Drs. Brown, Diehn, and Loo.\u201d (Int J Radiat Oncol Biol Phys 2011;79:1599-1600) and \u201cInfluence of tumor hypoxia on stereotactic ablative radiotherapy (SABR): response to Drs. Mayer and Timmerman.\u201d (Int J Radiation Oncol Biol Phys 2011;78:1600)","volume":"81","author":"Song","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1667\/RR2773.1","article-title":"Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS)","volume":"177","author":"Park","year":"2012","journal-title":"Radiat Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.10.059","article-title":"Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy","volume":"70","author":"Park","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B65","doi-asserted-by":"publisher","first-page":"957; author reply 958","DOI":"10.1016\/j.ijrobp.2008.06.1929","article-title":"Linear quadratics is alive and well: in regard to Park et\u00a0al. (Int J Radiat Oncol Biol Phys 2008;70:847-852)","volume":"72","author":"Fowler","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B66","doi-asserted-by":"publisher","first-page":"39ra48","DOI":"10.1126\/scitranslmed.3000864","article-title":"A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy","volume":"2","author":"Wang","year":"2010","journal-title":"Sci Transl Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.11.003","article-title":"Dose escalation, not \u201cnew biology,\u201d can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer","volume":"85","author":"Brown","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2013.03.013","article-title":"Radiobiology of stereotactic body radiation therapy\/stereotactic radiosurgery and the linear-quadratic model","volume":"87","author":"Song","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2013.08.027","article-title":"Use of the LQ model with large fraction sizes results in underestimation of isoeffect doses","volume":"109","author":"Sheu","year":"2013","journal-title":"Radiother Oncol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2013.07.022","article-title":"The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved","volume":"88","author":"Brown","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.03.027","article-title":"Dose escalation, not \u201cnew biology,\u201d can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer. In regard to Brown et al","volume":"89","author":"Rao","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.08.355","article-title":"A hypothesis: indirect cell death in the radiosurgery era","volume":"91","author":"Sperduto","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B73","article-title":"Beyond the linear quadratic model: intraoperative radiotherapy and normal tissue tolerance","volume":"4","author":"Emami","year":"2015","journal-title":"Transl Cancer Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.02.047","article-title":"Biological Principles of Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiation Surgery (SRS): Indirect Cell Death","author":"Song","year":"","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1120\/jacmp.v12i1.3365","article-title":"A quality assurance method with submillimeter accuracy for stereotactic linear accelerators","volume":"12","author":"Grimm","year":"2011","journal-title":"J Appl Clin Med Phys"},{"key":"B76","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ijrobp.2014.05.007","article-title":"Quantifying rigid and non-rigid motion of liver tumors during Stereotactic Body Radiotherapy (SBRT)","volume":"90","author":"Xu","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/mp.12272","article-title":"Small-Field Dose Measurements in Heterogeneous Media","volume":"44","author":"Xue","year":"2017","journal-title":"Med Phys"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2015.12.001","article-title":"Dose Tolerance for Stereotactic Body Radiation Therapy","volume":"26","author":"Grimm","year":"2016","journal-title":"Semin Rad Onc"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1118\/1.2962211","article-title":"Validity of inhomogeneity correction in small fields used in cyberknife","volume":"35","author":"Das","year":"2008","journal-title":"Med Phys"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.591430\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T09:12:11Z","timestamp":1612861931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.591430\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,9]]},"references-count":79,"alternative-id":["10.3389\/fonc.2020.591430"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.591430","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2021,2,9]]},"article-number":"591430"}}